Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Vinorelbine and Cisplatin in Completely Resected Non-Small Cell Lung Cancer
NCT00002583Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jul 1994
- Primary completion
- Apr 2004
- Modality
- Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of vinorelbine, Cisplatin micelle injection (HA132) in non-small cell lung cancer (NSCLC), sponsored by Canadian Cancer Trials Group. Started Jul 1994; status: completed.
02
Drugs
vinorelbineCisplatin micelle injection (HA132)
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00002583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002583.